Tranexamic acid in the control of spontaneous bleeding in severe haemophilia

MeSH terms

• Adolescent
• Age Factors
• Aminocaproates / therapeutic use
• Antifibrinolytic Agents / administration & dosage
• Antifibrinolytic Agents / adverse effects
• Antifibrinolytic Agents / therapeutic use*
• Blood Coagulation
• Child
• Cyclohexanecarboxylic Acids / administration & dosage
• Cyclohexanecarboxylic Acids / adverse effects
• Cyclohexanecarboxylic Acids / therapeutic use*
• Factor VIII / therapeutic use
• Follow-Up Studies
• Hemophilia A / complications
• Hemophilia A / drug therapy*
• Hemorrhage / etiology
• Hemorrhage / prevention & control
• Humans
• Male
• Phosphatidylethanolamines
• Time Factors